Read more
Focusing on the application of nanotechnology in pharmaceutical technology the editors seek to integrate the two in order to obtain innovative products and solutions in pharmacology. Interdisciplinary in content it is of interest to those who are involved in the development of nanoproducts including nanotechnologists, microbiologists, biotechnologists pharmacologists and clinicians. Recent studies are presented that include the biosynthesis of nanoparticles focusing on antimicrobials; nanomaterial-based formulations that treat cancer, infections, skin disorders and wounds;nanomaterials in eye diseases and toxicity and safety issues. It demonstrates the crucial role this plays in tackling multi-drug resistant threats.
List of contents
Section 1. General.- Bio-Inspired Metal Nanoparticles with Special Reference to Mechanism.- Bio-Inspired Metal Nanoparticles with Special Reference to Mechanism.- Nanoliposomes as a Platform to Deliver Antimicrobials.- Metal Oxide Nanoparticles in Medicine: Progress and Limitations.- Nanotechnology: A Tool For Targeted Drug Delivery.- Pharmaceutical Applications of Curcumin-Loaded Nanoparticles.- Section 2. Nanoparticles/ Nanoformulations for diseases and Patents.- Nanoformulation for Cancer Therapy.- Nanoformulations for Vaginal Therapy.- Nanoformulation for Wound Infections.- Lipid-based Nanoformulations for Skin Diseases Treatment.- Anti-Proliferative Activity of Curcumin Loaded PLGA Nanoparticles for Prostate Cancer.- Nanotechnological Interventions for Drug Delivery in Eye Diseases.- Role of Nanoparticles in Treatment of Human Parasites.- Patents survey: Treatment of Alzheimer's Disease Through Nanotechnology Based Drug Delivery System.- Section 3. Toxicity.- Nanoparticles in Medicine: Properties, Toxicity and Safety.
About the author
Mahendra Rai is a Professor and Head at the Department of Biotechnology, Sant Gadge Baba Amravati University at Amravati, Maharashtra, India. He was a Visiting Scientist at the Department of Bioenergetics, University of Geneva, Switzerland in 2004 and at the Department of Plant Protection of Debrecen University, Debrecen, Hungary in 2005 and 2008. He visited Department of Chemical Biology, University of Campinas, Brazil under Indo-Brazil Research Programme (DST-CNPq collaboration) in 2009, 2011 and 2012. In 2012, he was visiting Professor in Nicolaus Copernicus University, Torun, Poland. In 2013 he was invited by State University of Campinas, Brazil. He was also visiting professor in 2015 in Ostrava, Czech Republic. His area of expertise includes microbial biotechnology and nanobiotechnology. His present research interests are nanobiotechnology in medicine, agriculture and bioethanol production. He has published more than 325 research papers in national and international journals. In addition, he has edited/authored more than 40 books and 6 patents.
Carolina Alves dos Santos has Bachelor in Pharmaceutical Sciences from Pontifícia Universidade Católica de Campinas -Brazil (2004). She earned a PhD from University of São Paulo at School of Pharmaceutical Sciences-Brazil (2011); and post doctorate at Polytechnic School in University of São Paulo-Brazil (2014). Presently she is a Researcher at the University of Sorocaba-Brazil (2016). She has published 20 papers in international journals, 1 patent and presented papers in several conferences. Moreover, she has experience in the field of Pharmacy, with emphasis in Pharmaceutical Technology, working mainly on drug stability, biosensors, validation and development of analytical methodologies, nanotecnhology and nanobiotecnhology.
Summary
Focusing on the application of nanotechnology in pharmaceutical technology the editors seek to integrate the two in order to obtain innovative products and solutions in pharmacology. Interdisciplinary in content it is of interest to those who are involved in the development of nanoproducts including nanotechnologists, microbiologists, biotechnologists pharmacologists and clinicians. Recent studies are presented that include the biosynthesis of nanoparticles focusing on antimicrobials; nanomaterial-based formulations that treat cancer, infections, skin disorders and wounds;nanomaterials in eye diseases and toxicity and safety issues. It demonstrates the crucial role this plays in tackling multi-drug resistant threats.
